Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pliant Therapeutics
Biotech
Bayer taps new chief medical officer—Chutes & Ladders
Bayer taps new chief medical officer. Cantor steps into PhRMA’s house as CEO. Moderna veteran rejoins for second act.
Darren Incorvaia
,
Marissa Russo
,
Donavyn Coffey
,
James Waldron
Oct 2, 2026 8:30am
Pliant ends lung disease program over rise in adverse events
Jun 30, 2025 4:49am
Pliant cuts workforce by 45% after bexotegrast trial safety woes
May 2, 2025 7:33am
Pliant, Acelyrin take ‘poison pills’ as Concentra buyout looms
Mar 14, 2025 10:01am
Pliant terminates lung disease trial due to adverse events
Mar 3, 2025 11:30am
Pliant pauses lung fibrosis trial on advice of safety committee
Feb 10, 2025 4:18am